Gosuranemab
From EverybodyWiki Bios & Wiki
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Humanized (from mouse) |
| Target | tau protein |
| Clinical data | |
| Synonyms | BMS-986168; BIIB092 |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| UNII | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}} |
| Chemical and physical data | |
| Formula | C6434H9930N1706O2014S48 |
| Molar mass | 144.9 g/mol g·mol−1 |
Gosuranemab (BMS-986168; BIIB092) (INN) is a monoclonal antibody designed for the treatment of progressive supranuclear palsy and other tauopathies.[1][2]
This drug is being developed by Biogen Inc.
References[edit]
 | This monoclonal antibody–related article is a stub. You can help EverybodyWiki by expanding it. |
This article "Gosuranemab" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Gosuranemab. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
